Aspruzyo Sprinkle 500 mg extended-release granules in unit-dose sachets Images
Generic Name: ranolazine
This medication has been identified as Aspruzyo Sprinkle 500 mg extended-release granules in unit-dose sachets. It is supplied by Sun Pharmaceutical Industries Inc.
Aspruzyo Sprinkle is used in the treatment of Angina and belongs to the drug class antianginal agents. Risk cannot be ruled out during pregnancy. Aspruzyo Sprinkle 500 mg extended-release granules in unit-dose sachets is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Aspruzyo Sprinkle
- Generic Name
- ranolazine
- Strength
- 500 mg extended-release granules in unit-dose sachets
- Availability
- Prescription only
- Drug Class
- Antianginal agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 47335-0624
More about Aspruzyo Sprinkle (ranolazine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antianginal agents
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
